StockData

abrdn Life Sciences Investors (HQL) stock

HQLNYSEFiscal year ends September 30
$17.49−0.13 (-0.74%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Earnings

abrdn Life Sciences Investors's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of abrdn Life Sciences Investors's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

abrdn Life Sciences Investors has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When abrdn Life Sciences Investors puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases abrdn Life Sciences Investors filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?